Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesc Solé

Showing results (131-140 of 163) with videos related to

Pageof 17
Sort By:
British Journal of Haematology|July 23, 2013
Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletionAnna Puiggros, Julio Delgado, Ana Rodriguez-Vicente, et al.
Genes, Chromosomes & Cancer|July 25, 2019
Molecular profiling refines minimal residual disease-based prognostic assessment in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemiaJordi Ribera, Lurdes Zamora, Mireia Morgades, et al.
Leukemia & Lymphoma|March 11, 2015
Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromesJudit Sánchez-Castro, Víctor Marco-Betés, Xavier Gómez-Arbonés, et al.
British Journal of Haematology|October 18, 2019
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemiaLaura Palomo, Mariam Ibáñez, María Abáigar, et al.
Genes, Chromosomes & Cancer|September 11, 2015
Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control groupFriederike Braulke, Catharina Müller-Thomas, Katharina Götze, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2013
Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometryBlanca Espinet, Ana Ferrer, Beatriz Bellosillo, et al.
Leukemia Research|May 4, 2013
Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndromeJudit Sánchez-Castro, Víctor Marco-Betés, Xavier Gómez-Arbonés, et al.
Cancer Research|February 4, 2010
Genomic and gene expression profiling defines indolent forms of mantle cell lymphomaVerònica Fernàndez, Olga Salamero, Blanca Espinet, et al.
Blood|May 19, 2010
Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma GroupMarta Salido, Cristina Baró, David Oscier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database mergeJulie Schanz, Heinz Tüchler, Francesc Solé, et al.
Pageof 17

Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
British Journal of Haematology|July 23, 2013
Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletionAnna Puiggros, Julio Delgado, Ana Rodriguez-Vicente, et al.
Genes, Chromosomes & Cancer|July 25, 2019
Molecular profiling refines minimal residual disease-based prognostic assessment in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemiaJordi Ribera, Lurdes Zamora, Mireia Morgades, et al.
Leukemia & Lymphoma|March 11, 2015
Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromesJudit Sánchez-Castro, Víctor Marco-Betés, Xavier Gómez-Arbonés, et al.
British Journal of Haematology|October 18, 2019
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemiaLaura Palomo, Mariam Ibáñez, María Abáigar, et al.
Genes, Chromosomes & Cancer|September 11, 2015
Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control groupFriederike Braulke, Catharina Müller-Thomas, Katharina Götze, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2013
Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometryBlanca Espinet, Ana Ferrer, Beatriz Bellosillo, et al.
Leukemia Research|May 4, 2013
Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndromeJudit Sánchez-Castro, Víctor Marco-Betés, Xavier Gómez-Arbonés, et al.
Cancer Research|February 4, 2010
Genomic and gene expression profiling defines indolent forms of mantle cell lymphomaVerònica Fernàndez, Olga Salamero, Blanca Espinet, et al.
Blood|May 19, 2010
Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma GroupMarta Salido, Cristina Baró, David Oscier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database mergeJulie Schanz, Heinz Tüchler, Francesc Solé, et al.
Pageof 17